Targovax ASA logo

TRVX - Targovax ASA News Story

NOK6.33 -0.0  -0.2%

Last Trade - 12:15pm

Sector
Healthcare
Size
Micro Cap
Market Cap £41.6m
Enterprise Value £35.8m
Revenue £221k
Position in Universe 1021st / 1792

BRIEF-Targovax, Valo Therapeutics Enter Collaboration To Develop RAS

Wed 22nd April, 2020 6:07am
April 22 (Reuters) - Targovax ASA  TRVX.OL :
    * TARGOVAX AND VALO THERAPEUTICS ENTER COLLABORATION TO DEVELOP RAS
    * COLLABORATION COULD LEAD TO FURTHER DEVELOPMENT OF A FIRST-IN-CLASS MUTANT-RAS TARGETING
ONCOLYTIC VIRUS

Source text for Eikon:  ID:nObi6SVF4a 
Further company coverage:  TRVX.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.